Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Startseite
  2. Aktien
  3. Kanada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Psyched Wellness Ltd.
  6. News
  7. Andere Sprachen
    PSYC   CA74447P1009

PSYCHED WELLNESS LTD.

(PSYC)
Verzögert CANADIAN NATIONAL STOCK EXCHANGE  -  18:32:22 30.01.2023
0.0750 CAD    0.00%
2022Psyched Wellness Ltd. kündigt Kaufvertrag mit Choice Wholesale über 60.000 Einheiten ihrer Amanita Muscaria Tinktur 'Calm' an
CI
2022Psyched Wellness liefert Vorbestellungen von Calm aus und eröffnet den Online Shop wieder
CI
2022Psyched Wellness Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. August 2022
CI
ÜbersichtKurseChartsNewsTermineUnternehmenFinanzenDerivateFonds 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über PSYCHED WELLNESS LTD.
2022Psyched Wellness Ltd. Announces Purchase Agreement with Choice Wholesale for 60,000 Uni..
2022Psyched Wellness Delivers Pre-Orders of Calm and Reopens Online Store
2022Psyched Wellness Ltd. Reports Earnings Results for the Third Quarter and Nine Months En..
2022Psyched Wellness Announces Successful Pilot Run, Final Flavour Profile for Calm and Shi..
2022Psyched Wellness Provides Corporate Update
2022Psyched Wellness Ltd. Signs Two Long Term Supply Agreements for Amanita Muscaria Mushro..
2022Psyched Wellness Reports E-Commerce Fulfillment Partnership With ShipHero
2022Psyched Wellness Signs Up Toronto-Based Marketing Firm
2022Psyched Wellness Ltd. Announces Findings from an Ongoing Study with the National Resear..
2022Psyched Wellness : Q2 Interim Management Discussion and Analysis
2022Psyched Wellness : Q2 Interim Financial Report
2022Psyched Wellness Ltd. Reports Earnings Results for the Second Quarter and Six Months En..
2022Psyched Wellness Commences Preorders for Calm in Path to Commercialization of Proprieta..
2022Psyched Wellness Announces July 19th, 2022 as the Official Date to Commence Pre-Orders ..
2022Psyched Wellness announces date for their pilot production run of the first legal Amani..
2022Psyched Wellness Announces the Official Launch of Their New ecommerce Online Store
2022Psyched Wellness Receives $226,500 From Sale of Non-Core Assets
2022Psyched Wellness Announces Del Mahabadi to Join as International Marketing Manager
2022KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand..
2022Psyched Wellness Ltd. Announces Key Findings from the 90-Day Oral Toxicity Study on AME..
2022KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th
2022Psyched Wellness : to Participate in Upcoming Investor Conferences in April 2022
2022Psyched Wellness Ltd. Reports Earnings Results for the First Quarter Ended February 28,..
2022Psyched Wellness Ltd. Unveils New Product Name and Visual Identity Elements
2022Psyched Wellness Ltd. Reports Earnings Results for the Full Year Ended November 30, 202..
2022Psyched Wellness Ltd. Auditor Raises 'Going Concern' Doubt
2022Psyched Wellness Ltd Announces Preliminary Data from the National Research Council of C..
2022Psyched Wellness : and the National Research Council of Canada Announce Preliminary Data f..
2022Psyched Wellness Ltd. GARS Dossier Approve by Panel of Experts, Providing Green Light t..
2022Psyched Wellness Ltd. Announces Additional Positive Results from the 14-Day Oral Toxici..
2022Psyched Wellness : Announces Additional Positive Results From The 14-Day Oral Toxicity Stu..
2022Psyched Wellness : Announces Launch of New Logo, Branding, and Website, Prepares to Releas..
2022Psyched Wellness : Announces Path to Market for AME-1-derived Products in the USA
2022Psyched Wellness : Announces Completion of Its 90 Day Oral Toxicity Study
2022Psyched Wellness Provides Update on Anti-Inflammatory Study with the National Research ..
2021Psyched Wellness Announces Path to Market for AME-1-Derived Products in the USA
2021Psyched Wellness Ltd. Announces Completion of its 90 Day Oral Toxicity Study
2021Psyched Wellness Ltd. Appoints Matthew Singh as Chief Commercial Officer
2021Psyched Wellness Announces That the Amanita Muscaria Mushroom Has Been Successfully Add..
2021Psyched Wellness Announces Amanita Muscaria Mushroom Successfully Added to the Natural ..
2021Psyched Wellness Ltd. Reports Earnings Results for the Third Quarter and Nine Months En..
2021Psyched Wellness : Announces Preliminary Data Showing Potential New Functional Property an..
2021Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property a..
2021KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Vie..
2021Psyched Wellness : to Webcast Live at the KCSA Psychedelics Virtual Investor Conference on..
2021KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
2021Psyched Wellness : Announces Commencement of Next Pre-Clinical Study on AME-1
2021Psyched Wellness Ltd. Announces Commencement of Next Pre-Clinical Study on AME-1
2021Psyched Wellness : Announces Inclusion in AdvisorShares Psychedelics Exchange Traded Fund
2021Psyched Wellness : Announces Inclusion in AdvisorShares Psychedelics Exchange Traded Fund ..
2021Psyched Wellness : Initiates a Clinical Sleep Study on Humans for a Structure/Function Cla..
2021Psyched Wellness Initiates Clinical Sleep Study on Humans for A Structure/Function Clai..
2021Psyched Wellness : Announces Participation in the H.C. Wainwright 23rd Annual Global Inves..
2021Psyched Wellness Announces Participation in the H.C. Wainwright 23rd Annual Global Inve..
2021Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on Ame-1
2021Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1
2021Psyched Wellness Submits Applications for Four Further Provisional Patents Surrounding ..
2021Psyched Wellness Ltd. Reports Earnings Results for the Second Quarter Ended May 31, 202..
2021Psyched Wellness Enters into a Service Agreement with CannaLabs to Begin Stability Test..
2021Psyched Wellness Announces Filing of Amended and Restated MD&A
2021Psyched Wellness Ltd. Successfully Completes Its Large Extraction and Shipment of AME-1..
2021Psyched Wellness Successfully Completes Its Largest Extraction and Shipment of AME-1 to..
2021Psyched Wellness Ltd. Announces Appointment of Amanda Galbraith to Its Board of Directo..
2021Amanda Galbraith, Principal at Navigator Joins the Board of Psyched Wellness
2021Psyched Wellness : Receives Positive Results from It's 14-Day Oral Toxicity Preclinical St..
2021Psyched Wellness Ltd. Receives Positive Results from It's 14-Day Oral Toxicity Preclini..
2021Psyched Wellness Receives Positive Results from It's 14-Day Oral Toxicity Preclinical S..
2021Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding Consultant
2021Psyched Wellness : Commences Next PreClinical Study on AME-1
2021Psyched Wellness Commences Next Pre- Clinical Study on AME-1
2021Psyched Wellness Commences Next Pre-Clinical Study on AME-1
2021Psyched Wellness Ltd. to Present at H.C. Wainwright Conference on June 17, 2021
2021Psyched Wellness Hires Ad Agency, dacs Marketing to Build the Branding and Marketing St..
2021May Psychedelic Capital Investigates Financial Media and Equality in the Boardroom
2021Psyched Wellness to Present at the Psychedelic Investment Series on Monday, May 31, 202..
2021Psyched Wellness Hires the National Research Council of Canada to Test AME-1
2021Psyched Wellness Signs Supply Agreement for Amanita Muscaria
2021Psyched Wellness Signs Supply Agreement for Amanita Muscaria
2021Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1
2021Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1
2021Psyched Wellness Ltd. Reports Earnings Results for the First Quarter Ended February 28,..
2021Psyched Wellness Receives DTC Eligibility
2021Psyched Wellness Ltd. Signs an Additional Agreement with KGK Science
2021Psyched Wellness Initiates Study on AME-1 Extract for Gut Health
2021Psyched Wellness Submits a Provisional Patent Application For AME-1
2021Psyched Wellness Ltd. Announces Board Changes
2021Psyched Wellness Announces Changes to the Board of Directors
2021Psyched Wellness Ltd. Provides Update on Pre-Clinical Trial of its Muscimol Extract AME..
2021Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1
2021Psyched Wellness Ltd. announced that it has received CAD 6.603 million in funding
2021Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol
2021Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol
2021Psyched Wellness to Participate in Canaccord Genuity's New Paradigms and Treatment Appr..
2021Psyched Wellness Ltd. Reports Earnings Results for the Full Year Ended November 30, 202..
2021Psyched Wellness Included in First Psychedelic Exchange Traded Fund
2021Psyched Wellness : Up 15%, Has Hit 52 Week Highs After Upsizing Previou..
2021Psyched Wellness to Present at Inaugural KCSA Psychedelics Investor Conference
2021Re-release : Psyched Wellness Upsizes Previously Announced Bought Deal Offering
2021Psyched Wellness : Upsizes Previously Announced Bought Deal Offering
2021Psyched Wellness : Upsizes Previously Announced Bought Deal Offering
Anstehende Termine für PSYCHED WELLNESS LTD.